{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:06Z","timestamp":1793212086815,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012856","name":"Alberta Children's Hospital Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cgh.2024.07.007","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T22:11:54Z","timestamp":1722377514000},"page":"835-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on Biologics"],"prefix":"10.1016","volume":"23","author":[{"given":"Kenneth","family":"Ernest-Suarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Murgu\u00eda-Favela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taj","family":"Jadavji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-9054","authenticated-orcid":false,"given":"Cynthia H.","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.07.007_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.007_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","article-title":"European Crohn\u2019s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation","volume":"17","author":"Torres","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.07.007_bib3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","article-title":"inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group","volume":"156","author":"Mahadevan","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.007_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease","volume":"160","author":"Mahadevan","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.007_bib5","doi-asserted-by":"crossref","first-page":"E1129","DOI":"10.1503\/cmaj.202391","article-title":"The use and impact of monoclonal antibody biologics during pregnancy","volume":"193","author":"Pham-Huy","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.cgh.2024.07.007_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2352-4642(23)00136-0","article-title":"Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network","volume":"7","author":"Fitzpatrick","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cgh.2024.07.007_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ibd\/izab033","article-title":"Suboptimal vaccination administration in mothers with inflammatory bowel disease and their biologic-exposed infants","volume":"28","author":"Chiarella-Redfern","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.07.007_bib8","first-page":"e72","article-title":"Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines","volume":"4","author":"Jones","year":"2021","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"key":"10.1016\/j.cgh.2024.07.007_bib9","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1093\/rheumatology\/keac141","article-title":"A\u00a0systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero","volume":"61","author":"Goulden","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.cgh.2024.07.007_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2020.12.079","article-title":"Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines","volume":"161","author":"Benchimol","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.007_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.007_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jpids\/piac101","article-title":"Rotavirus vaccine impact within an integrated healthcare delivery system in the United States","volume":"11","author":"Burke","year":"2022","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"key":"10.1016\/j.cgh.2024.07.007_bib14","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1016\/j.vaccine.2016.03.047","article-title":"Brighton Collaboration Congenital Anomalies Working Group. Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"DeSilva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2024.07.007_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.007_bib16","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1007\/s10620-023-08016-x","article-title":"Decreased risk of preeclampsia in women with inflammatory bowel disease on anti-tumor necrosis factor therapy","volume":"68","author":"Patel","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.07.007_bib17","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.7326\/M22-0819","article-title":"Benefits and risks associated with continuation of anti-tumor necrosis factor after 24 weeks of pregnancy in women with inflammatory bowel disease: a nationwide emulation trial","volume":"175","author":"Meyer","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2024.07.007_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cgh.2023.12.029","article-title":"Safety of vedolizumab and ustekinumab compared with anti-TNF in pregnant women with inflammatory bowel disease","volume":"23","author":"Meyer","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.007_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/apt.14040","article-title":"The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease","volume":"45","author":"Seow","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.07.007_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2024.02.025","article-title":"Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel\u00a0disease and infants exposed in utero","volume":"23","author":"Prentice","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.007_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cgh.2012.10.024","article-title":"Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure","volume":"11","author":"Zelinkova","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.007_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-TNF-\u03b1 during pregnancy","volume":"8","author":"Esteve-Sol\u00e9","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cgh.2024.07.007_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41424-018-0018-3","article-title":"Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants","volume":"9","author":"Kattah","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2024.07.007_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.935034","article-title":"Immune function in newborns with in-utero exposure to anti-TNF\u03b1 therapy","volume":"10","author":"Weiss","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.cgh.2024.07.007_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051819","article-title":"Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2024.07.007_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cgh.2019.03.037","article-title":"Appropriate therapeutic drug monitoring of biologic agents for patients with inflammatory bowel diseases","volume":"17","author":"Papamichael","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.07.007_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpobgyn.2019.11.003","article-title":"Long-term outcome of children born from mothers with autoimmune diseases","volume":"64","author":"Nalli","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.cgh.2024.07.007_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3345\/cep.2021.00864","article-title":"Pathophysiology, classification, and complications of common asymptomatic thrombocytosis in newborn infants","volume":"65","author":"Jeon","year":"2022","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.cgh.2024.07.007_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2020.11.050","article-title":"Longitudinal changes in fecal calprotectin levels among pregnant women with and without inflammatory bowel disease and their babies","volume":"160","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.07.007_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gutjnl-2018-317855","article-title":"Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice","volume":"69","author":"Torres","year":"2020","journal-title":"Gut"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524006773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524006773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:12:55Z","timestamp":1762549975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524006773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1542356524006773"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.07.007","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on Biologics","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}